Science and Research

TNF Superfamily Member 14 Drives Post-Influenza Depletion of Alveolar Macrophages Enabling Secondary Pneumococcal Pneumonia

Secondary bacterial infection, often caused by Streptococcus pneumoniae (Spn), is one of the most frequent and severe complications of influenza A virus (IAV)-induced pneumonia. Phenotyping of the pulmonary immune cell landscape after IAV infection revealed a substantial depletion of the tissue-resident alveolar macrophage (TR-AM) population at day 7, which was associated with increased susceptibility to Spn outgrowth. To elucidate the molecular mechanisms underlying TR-AM depletion, and to define putative targets for treatment, we combined single-cell transcriptomics and cell-specific PCR profiling in an unbiased manner, using in vivo models of IAV infection and IAV/Spn co-infection. The TNF superfamily 14 (TNFSF14) ligand-receptor axis was revealed as the driving force behind post-influenza TR-AM death during the early infection phase, enabling the transition to pneumococcal pneumonia, while intrapulmonary transfer of genetically modified TR-AMs and antibody-mediated neutralization of specific pathway components alleviated disease severity. With a mainly neutrophilic expression and a high abundance in the bronchoalveolar fluid (BALF) of patients with severe virus-induced ARDS, TNFSF14 emerged as a key determinant of virus-driven lung injury. Targeting the TNFSF14-mediated intercellular communication network in the virus-infected lung can, therefore, improve host defense, minimizing the risk of subsequent bacterial pneumonia, and ameliorating disease outcome.

  • Malainou, C.
  • Peteranderl, C.
  • Ferrero, M. R.
  • Vazquez-Armendariz, A. I.
  • Alexopoulos, I.
  • Franz, K.
  • Knippenberg, K.
  • Better, J.
  • Estiri, M.
  • Wu, C. Y.
  • Schultheis, H.
  • Bushe, J.
  • Del Rio, M. L.
  • Rodriguez-Barbosa, J. I.
  • Pfeffer, K.
  • Günther, S.
  • Looso, M.
  • Gruber, A. D.
  • Vadász, I.
  • Matt, U.
  • Herold, S.

Keywords

  • Bacterial infections
  • Cell biology
  • Infectious disease
  • Influenza
Publication details
DOI: 10.1172/jci185390
Journal: J Clin Invest
Work Type: Original
Location: UGMLC
Disease Area: PALI
Partner / Member: JLU
Access-Number: 41252214


chevron-down